ClinicalTrials.gov
ClinicalTrials.gov Menu

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00193024
Recruitment Status : Terminated
First Posted : September 19, 2005
Last Update Posted : May 3, 2011
Sponsor:
Collaborators:
Aventis Pharmaceuticals
Pharmacia and Upjohn
Information provided by:
SCRI Development Innovations, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2003
  Actual Study Completion Date : October 2004